Question 1

How does Highmark Blue Cross Blue Shield rank in research?

Accepted Answer

Highmark Blue Cross Blue Shield ranks #26,204 of 34,923 institutions worldwide on research quality over all time, and #5,484 of 7,310 in the United States.

Question 2

Who are the top researchers at Highmark Blue Cross Blue Shield?

Accepted Answer

Ranked on the quality score, Donald E. Fetterolf, Richard L. Snyder and Tyson Barrett lead among researchers whose main affiliation is Highmark Blue Cross Blue Shield.

Question 3

What are the most cited papers from Highmark Blue Cross Blue Shield?

Accepted Answer

The most cited paper from Highmark Blue Cross Blue Shield is "Employee Participation: Diverse Forms and Different Outcomes" (John Lawrence Cotton, David A. Vollrath, Kirk L. Froggatt et al., 1988), with 719 citations. Next come "The Impact of the Highmark Employee Wellness Programs on 4-Year Healthcare Costs" (206) and "Impact of Periodontal Therapy on General Health" (201).

Question 4

Which research topics does Highmark Blue Cross Blue Shield publish most on?

Accepted Answer

By volume in 2022-now: Food Security and Health in Diverse Populations, Healthcare innovation and challenges, Health and Well-being Studies and Big Data and Business Intelligence.

Question 5

Which keywords describe research at Highmark Blue Cross Blue Shield?

Accepted Answer

By fractional works in 2022-now, weighted toward what it does more of than the world: Depression, Mental Health, Social Support, Epidemiology, Clinical Trials, Primary Care, Health Outcomes and Chronic Disease.

Question 6

Which fields of science does Highmark Blue Cross Blue Shield work in?

Accepted Answer

In 2022-now, 56% of research at Highmark Blue Cross Blue Shield is in Health Sciences, 23% in Social Sciences. Its largest fields are Medicine (43%), Health Professions (11%), Social Sciences (8%). It does 2.2× the world's share of Health Sciences.

Question 7

Is Highmark Blue Cross Blue Shield's research output growing?

Accepted Answer

Output in 2022-2025 was 203% higher than in 2018-2021.